Aniket Zinzuwadia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Aniket Zinzuwadia has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Michael T. Lu
Cardiovascular Imaging Research Center (CIRC), Department of Radiology (I.H., J.M.B., M.J., L.H.C., S.E., I.L.L., M.C.L., S.A., V.K.R., B.G., S.H., A.T., M.T.L., B.F.), Massachusetts General Hospital, Harvard Medical School, Boston
3 shared publications - Vineet K. Raghu
Massachusetts General Hospital
3 shared publications - Hugo J. W. L. Aerts
Radiology and Nuclear Medicine, CARIM & GROW, Maastricht University, the Netherlands (I.H., H.J.W.L.A.).
2 shared publications Jakob Weiss
2 shared publicationsAdrian F Hernandez
1 shared publicationAnika S Walia
1 shared publication
Latest Publications
- Open Access
- 25 October 2025
- Published by Elsevier in The Lancet Digital Health
- Vol. 7 (9)
Leveraging deep learning applied to chest radiograph images to identify individuals at high risk of chronic obstructive pulmonary disease: a retrospective model validation study
- 25 October 2025
- Published by Elsevier in The Lancet Digital Health
- Vol. 7 (9)
Open AccessLeveraging deep learning applied to chest radiograph images to identify individuals at high risk of chronic obstructive pulmonary disease: a retrospective model validation study
- 1 October 2024
- Published by BMJ in BMJ Innovations
- Vol. 10 (4) , 115-123
Impact of a virtual cardiology programme for postdischarge patients with cardiovascular disease: a matched cohort analysis
Introduction: Telemedicine programmes have shown promise in reducing hospital readmissions, but varied RPM strategies and study populations have contributed to mixed results. Here, we evaluate a standardised virtual care programme in discharged patients with cardiovascular disease (CVD).Methods: We conducted an open-label prospective randomised study on discharged patients with known CVD comparing those who received a 100-day postdischarge virtual cardiology programme with individuals receiving standard cardiology care. The care programme consisted of telemedicine, RPM and medication titration. The study included patients recently followed by a partnering cardiology practice. Intervention patients with low engagement and late postdischarge onboarding were excluded from analysis. Control patients were matched 1:1 to the intervention patients. Readmission data were collected using an admission notification system. Statistical significance at 90 days was established via Cox proportional hazard analysis.Results: The matched cohort included 95 patients each in the intervention and control groups, aged 69 years, enrolled February 2021–May 2022. Intervention patients had on average 10.1 visits and 4.3 medication changes. Relative to controls, intervention patients had significantly lower rates of cardiac (8.4% vs 17.9%, p=0.04) and all-cause (15.8% vs 28.4%, p=0.02) readmissions over 90 days post discharge. They also experienced weight loss (4.5 pounds), reduced systolic blood pressure (−11.0 mm Hg) and improved dyspnoea during exercise and daily activities.Conclusion: In this matched cohort analysis of recently hospitalised patients with CVD, a postdischarge virtual cardiology programme combined with traditional outpatient follow-up reduced readmissions when compared with traditional care alone.
- 1 October 2024
- Published by BMJ in BMJ Innovations
- Vol. 10 (4) , 115-123
Impact of a virtual cardiology programme for postdischarge patients with cardiovascular disease: a matched cohort analysis
Introduction: Telemedicine programmes have shown promise in reducing hospital readmissions, but varied RPM strategies and study populations have contributed to mixed results. Here, we evaluate a standardised virtual care programme in discharged patients with cardiovascular disease (CVD).Methods: We conducted an open-label prospective randomised study on discharged patients with known CVD comparing those who received a 100-day postdischarge virtual cardiology programme with individuals receiving standard cardiology care. The care programme consisted of telemedicine, RPM and medication titration. The study included patients recently followed by a partnering cardiology practice. Intervention patients with low engagement and late postdischarge onboarding were excluded from analysis. Control patients were matched 1:1 to the intervention patients. Readmission data were collected using an admission notification system. Statistical significance at 90 days was established via Cox proportional hazard analysis.Results: The matched cohort included 95 patients each in the intervention and control groups, aged 69 years, enrolled February 2021–May 2022. Intervention patients had on average 10.1 visits and 4.3 medication changes. Relative to controls, intervention patients had significantly lower rates of cardiac (8.4% vs 17.9%, p=0.04) and all-cause (15.8% vs 28.4%, p=0.02) readmissions over 90 days post discharge. They also experienced weight loss (4.5 pounds), reduced systolic blood pressure (−11.0 mm Hg) and improved dyspnoea during exercise and daily activities.Conclusion: In this matched cohort analysis of recently hospitalised patients with CVD, a postdischarge virtual cardiology programme combined with traditional outpatient follow-up reduced readmissions when compared with traditional care alone.
- 1 June 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 17 (6) , e010439
Defining a Minimal Benchmark for Cardiovascular Risk Prediction Calculators in New England Electronic Health Record–Derived Cohort
- 1 June 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 17 (6) , e010439
Defining a Minimal Benchmark for Cardiovascular Risk Prediction Calculators in New England Electronic Health Record–Derived Cohort
- 1 April 2024
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 177 (4) , 409-417
Deep Learning to Estimate Cardiovascular Risk From Chest Radiographs
Current guidelines recommend estimating the 10-year risk for major adverse cardiovascular events before deciding whether to initiate statin therapy for the primary prevention of atherosclerotic car... Visual Deep Learning to Estimate Cardiovascular Risk From Chest Radiographs Current guidelines recommend estimating the 10-year risk for major adverse cardiovascular events before deciding... Background: Guidelines for primary prevention of atherosclerotic cardiovascular disease (ASCVD) recommend a risk calculator (ASCVD risk score) to estimate 10-year risk for major adverse cardiovascu...
- 1 April 2024
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 177 (4) , 409-417
Deep Learning to Estimate Cardiovascular Risk From Chest Radiographs
Current guidelines recommend estimating the 10-year risk for major adverse cardiovascular events before deciding whether to initiate statin therapy for the primary prevention of atherosclerotic car... Visual Deep Learning to Estimate Cardiovascular Risk From Chest Radiographs Current guidelines recommend estimating the 10-year risk for major adverse cardiovascular events before deciding... Background: Guidelines for primary prevention of atherosclerotic cardiovascular disease (ASCVD) recommend a risk calculator (ASCVD risk score) to estimate 10-year risk for major adverse cardiovascu...
- 1 November 2023
- Published by American College of Physicians in Annals of Internal Medicine: Clinical Cases
- Vol. 2 (11)
Inguinal Lymphadenitis After Mpox Infection: A Case Report
- 1 November 2023
- Published by American College of Physicians in Annals of Internal Medicine: Clinical Cases
- Vol. 2 (11)
Inguinal Lymphadenitis After Mpox Infection: A Case Report
- Open Access
- 9 March 2023
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 93 (2) , 409-418
Congenitally Fused Cervical Spine Is Associated With Adjacent-Level Degeneration in the Absence of Cervical Spine Surgery
BACKGROUND: Cervical fusion surgery is associated with adjacent-level degeneration, but surgical and technical factors are difficult to dissociate from the mechanical effects of the fusion itself. OBJECTIVE: To determine the effect of fusion on adjacent-level degeneration in unoperated patients using a cohort of patients with congenitally fused cervical vertebrae. METHODS: We identified 96 patients with incidental single-level cervical congenital fusion on computed tomography imaging. We compared these patients to an age-matched control cohort of 80 patients without congenital fusion. We quantified adjacent-level degeneration through direct measurements of intervertebral disk parameters as well as the validated Kellgren & Lawrence classification scale for cervical disk degeneration. Ordinal logistic regression and 2-way analysis of variance testing were performed to correlate extent of degeneration with the congenitally fused segment. RESULTS: Nine hundred fifty-five motion segments were analyzed. The numbers of patients with C2-3, C3-4, C4-5, C5-6, and C6-7 congenitally fused segments were 47, 11, 11, 17, and 9, respectively. We found that patients with congenital fusion at C4-C5 and C5-C6 had a significantly greater extent of degeneration at adjacent levels compared with the degree of degeneration at the same levels in control patients and in patients with congenital fusion at other cervical levels, even while controlling for expected degeneration and age. CONCLUSION: Taken together, our data suggest that congenitally fused cervical spinal segments at C4-C5 and C5-C6 are associated with adjacent-level degeneration independent of fixation instrumentation. This study design removes surgical factors that might contribute to adjacent-level degeneration.
- 9 March 2023
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 93 (2) , 409-418
Open AccessCongenitally Fused Cervical Spine Is Associated With Adjacent-Level Degeneration in the Absence of Cervical Spine Surgery
BACKGROUND: Cervical fusion surgery is associated with adjacent-level degeneration, but surgical and technical factors are difficult to dissociate from the mechanical effects of the fusion itself. OBJECTIVE: To determine the effect of fusion on adjacent-level degeneration in unoperated patients using a cohort of patients with congenitally fused cervical vertebrae. METHODS: We identified 96 patients with incidental single-level cervical congenital fusion on computed tomography imaging. We compared these patients to an age-matched control cohort of 80 patients without congenital fusion. We quantified adjacent-level degeneration through direct measurements of intervertebral disk parameters as well as the validated Kellgren & Lawrence classification scale for cervical disk degeneration. Ordinal logistic regression and 2-way analysis of variance testing were performed to correlate extent of degeneration with the congenitally fused segment. RESULTS: Nine hundred fifty-five motion segments were analyzed. The numbers of patients with C2-3, C3-4, C4-5, C5-6, and C6-7 congenitally fused segments were 47, 11, 11, 17, and 9, respectively. We found that patients with congenital fusion at C4-C5 and C5-C6 had a significantly greater extent of degeneration at adjacent levels compared with the degree of degeneration at the same levels in control patients and in patients with congenital fusion at other cervical levels, even while controlling for expected degeneration and age. CONCLUSION: Taken together, our data suggest that congenitally fused cervical spinal segments at C4-C5 and C5-C6 are associated with adjacent-level degeneration independent of fixation instrumentation. This study design removes surgical factors that might contribute to adjacent-level degeneration.
- 1 June 2022
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 40 (16_suppl) , 10507
Clinical validation of a deep-learning–based model to predict lung cancer risk from chest X-rays.
10507 Background: Screening with chest CT prevents lung cancer death, but only 5% of eligible Americans are screened. The updated 2022 Centers for Medicare and Medicaid Services (CMS) criteria expand eligibility to 50-77 year-olds, current or former (3.5%, above accepted screening risk thresholds of >1.5% and >2%. Conclusions: Using routine CXRs from the EMR, CXR-LC identified high-risk smokers who may benefit from LCS with CT, complementary to the 2022 CMS eligibility criteria.
- 1 June 2022
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 40 (16_suppl) , 10507
Clinical validation of a deep-learning–based model to predict lung cancer risk from chest X-rays.
10507 Background: Screening with chest CT prevents lung cancer death, but only 5% of eligible Americans are screened. The updated 2022 Centers for Medicare and Medicaid Services (CMS) criteria expand eligibility to 50-77 year-olds, current or former (3.5%, above accepted screening risk thresholds of >1.5% and >2%. Conclusions: Using routine CXRs from the EMR, CXR-LC identified high-risk smokers who may benefit from LCS with CT, complementary to the 2022 CMS eligibility criteria.